David R. Bauer
Lawyers
Filters
Arrival $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
TruArc Partners acquisition of Molded Devices
We advised TruArc Partners on the transaction
Intel $6 billion senior notes offering
The investment-grade notes were offered in five tranches, including a sustainability tranche
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $264.5 million follow-on offering
The shares are listed on Nasdaq
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Applied Therapeutics $30 million stock and warrants offering
The stock is listed on the Nasdaq Global Market